Anti-resistance drug design strategies and corresponding inhibitors for SARS-CoV-2, HIV-1, MPXV, IAV and HBV.
Credit
HIGHER EDUCATON PRESS
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.